HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tien Hoang Selected Research

cyclopropapyrroloindole

10/2020Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tien Hoang Research Topics

Disease

13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 12/2002
11Neoplasms (Cancer)
10/2020 - 04/2006
2Adenocarcinoma
11/2017 - 07/2013
2Squamous Cell Carcinoma of Head and Neck
04/2015 - 08/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2013 - 04/2006
2Lung Neoplasms (Lung Cancer)
04/2006 - 12/2002
1Melanoma (Melanoma, Malignant)
10/2020
1Carcinoma (Carcinomatosis)
10/2020
1Fatigue
11/2017
1Disease Progression
11/2017
1Neutropenia
11/2017
1AIDS-Related Complex (ARC)
04/2017
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Hypoxia (Hypoxemia)
04/2015
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2014
1Peripheral Nervous System Diseases (PNS Diseases)
02/2014
1Neoplasm Metastasis (Metastasis)
09/2012
1Vascular Tissue Neoplasms
04/2012
1Diarrhea
05/2011
1Mucositis
05/2011
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2003
1Brain Neoplasms (Brain Tumor)
10/2003

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
11/2017 - 04/2015
3Bevacizumab (Avastin)FDA Link
04/2015 - 04/2012
3VorinostatFDA Link
02/2014 - 09/2013
3Bortezomib (Velcade)FDA Link
02/2014 - 09/2013
2Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2017
2rilotumumabIBA
11/2017 - 01/2017
2Epirubicin (Ellence)FDA LinkGeneric
11/2017 - 01/2017
2Capecitabine (Xeloda)FDA Link
11/2017 - 01/2017
2Carboplatin (JM8)FDA LinkGeneric
09/2012 - 02/2012
2Paclitaxel (Taxol)FDA LinkGeneric
09/2012 - 02/2012
2sulindac sulfone (exisulind)IBA
09/2008 - 03/2006
2GemcitabineFDA Link
03/2006 - 10/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020
1cyclopropapyrroloindoleIBA
10/2020
1Immune Checkpoint InhibitorsIBA
10/2020
1AntibodiesIBA
01/2018
1LigandsIBA
11/2017
1OxidesIBA
04/2017
1Stainless Steel (Steel, Stainless)IBA
04/2017
1MetalsIBA
04/2017
1Monoclonal AntibodiesIBA
01/2017
1Biological ProductsIBA
04/2015
1Diacetyl (Biacetyl)IBA
04/2015
1copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
04/2015
1taxaneIBA
02/2014
1Proteins (Proteins, Gene)FDA Link
07/2013
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2012
1Serum AlbuminIBA
09/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2012
1Thalidomide (Thalomid)FDA Link
02/2012
1Sunitinib (Sutent)FDA Link
05/2011
1Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2011
1Gefitinib (Iressa)FDA Link
04/2009
1Fulvestrant (Faslodex)FDA Link
04/2009
1ErbB Receptors (EGF Receptor)IBA
04/2009
1Estradiol (Delestrogen)FDA LinkGeneric
04/2009
1Estrogen Receptor betaIBA
04/2009
1Vinorelbine (Navelbine)FDA LinkGeneric
09/2008
1matrigelIBA
04/2006
1N-acetylcochinol-O-phosphateIBA
04/2006
1Antineoplastic Agents (Antineoplastics)IBA
03/2006

Therapy/Procedure

8Therapeutics
10/2020 - 12/2002
6Drug Therapy (Chemotherapy)
11/2017 - 12/2002
3Radiotherapy
08/2014 - 12/2002
2Chemoradiotherapy
08/2014 - 02/2012
1Immunotherapy
01/2018